ArticleJournal of cancer research and clinical oncology2015

Inhibition of 32Dp210 cells harboring T315I mutation by a novel derivative of emodin correlates with down-regulation of BCR-ABL and its downstream signaling pathways.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.